Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients

L. Canti; S. Humblet-Baron; I. Desombere; P. Pannus; A. Henry; S. Servais; E. Willems; K. K. Arien; Y. Beguin; M. E. Goossens; A. Marchant; F. Baron

doi:10.1038/s41409-022-01798-0

Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients

L. Canti, S. Humblet-Baron, I. Desombere, P. Pannus, A. Henry, S. Servais, E. Willems, K. K. Arien, Y. Beguin, M. E. Goossens, A. Marchant, F. Baron

Research output: Contribution to journal › Conference abstract in journal

Original language	English
Article number	P324
Journal	Bone Marrow Transplantation
Volume	57
Issue number	Suppl.1
Pages (from-to)	280-280
Number of pages	1
ISSN	0268-3369
DOIs	https://doi.org/10.1038/s41409-022-01798-0
Publication status	Published - 2022

Access to Document

10.1038/s41409-022-01798-0

Cite this

Canti, L., Humblet-Baron, S., Desombere, I., Pannus, P., Henry, A., Servais, S., Willems, E., Arien, K. K., Beguin, Y., Goossens, M. E., Marchant, A., & Baron, F. (2022). Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients. Bone Marrow Transplantation, 57(Suppl.1), 280-280. Article P324. https://doi.org/10.1038/s41409-022-01798-0

@article{d95a8d92dc48451cbcb584804dd46372,

title = "Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients",

author = "L. Canti and S. Humblet-Baron and I. Desombere and P. Pannus and A. Henry and S. Servais and E. Willems and Arien, {K. K.} and Y. Beguin and Goossens, {M. E.} and A. Marchant and F. Baron",

note = "NPP",

year = "2022",

doi = "10.1038/s41409-022-01798-0",

language = "English",

volume = "57",

pages = "280--280",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "Suppl.1",

}

Canti, L, Humblet-Baron, S, Desombere, I, Pannus, P, Henry, A, Servais, S, Willems, E , Arien, KK, Beguin, Y, Goossens, ME, Marchant, A & Baron, F 2022, 'Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients', Bone Marrow Transplantation, vol. 57, no. Suppl.1, P324, pp. 280-280. https://doi.org/10.1038/s41409-022-01798-0

TY - JOUR

T1 - Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients

AU - Canti, L.

AU - Humblet-Baron, S.

AU - Desombere, I.

AU - Pannus, P.

AU - Henry, A.

AU - Servais, S.

AU - Willems, E.

AU - Arien, K. K.

AU - Beguin, Y.

AU - Goossens, M. E.

AU - Marchant, A.

AU - Baron, F.

N1 - NPP

PY - 2022

Y1 - 2022

U2 - 10.1038/s41409-022-01798-0

DO - 10.1038/s41409-022-01798-0

M3 - Conference abstract in journal

SN - 0268-3369

VL - 57

SP - 280

EP - 280

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - Suppl.1

M1 - P324

ER -